A feature story in Discover magazine rounds up the progress that personal genomics companies have made in 2007, as well as what consumers should expect from them. Though some tests can make relatively concrete predictions (like Agendia's FDA-approved MammaPrint), SNP screening can only offer the probability of developing a certain disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.